Neoadjuvant TherapyBreast NeoplasmsInflammatory Breast NeoplasmsTriple Negative Breast NeoplasmsBreastBreast Neoplasms, MaleChemotherapy, AdjuvantCarcinoma, Ductal, BreastAntineoplastic Combined Chemotherapy ProtocolsNeoplasm StagingChemoradiotherapy, AdjuvantBreast DiseasesTreatment OutcomeRectal NeoplasmsPrognosisReceptors, EstrogenRadiotherapy, AdjuvantCombined Modality TherapyReceptor, erbB-2FluorouracilDisease-Free SurvivalTaxoidsPancreatic NeoplasmsEpirubicinEsophagectomyTumor Markers, BiologicalReceptors, ProgesteroneAntineoplastic AgentsAdenocarcinomaNeoplasm Recurrence, LocalBreast FeedingCisplatinNeoplasm InvasivenessRetrospective StudiesDoxorubicinEsophageal NeoplasmsCarcinoma, LobularNeoplasmsLymphatic MetastasisImmunohistochemistryCyclophosphamideSurvival RateMastectomyAntineoplastic Agents, HormonalSurvival AnalysisMammographyAnthracyclinesCarcinomaNeoplasm MetastasisGene Expression Regulation, NeoplasticBone NeoplasmsTamoxifenChemoradiotherapyMuscle NeoplasmsFollow-Up StudiesCell Line, TumorCystectomyMastectomy, SegmentalDeoxycytidineProspective StudiesKi-67 AntigenUltrasonography, MammaryNeoplasms, Cystic, Mucinous, and SerousNeoplasm, ResidualPaclitaxelBiomarkers, PharmacologicalAntibodies, Monoclonal, HumanizedFibrocystic Breast DiseaseLung NeoplasmsAxillaPredictive Value of TestsKaplan-Meier EstimateNeoplasm ProteinsOvarian NeoplasmsNitrilesNeoplasm GradingUrinary Bladder NeoplasmsNeoplasms, Multiple PrimaryOsteosarcomaLiver NeoplasmsSkin NeoplasmsBreast ImplantsBridged CompoundsCarcinoma, Squamous CellTime FactorsDNA, NeoplasmRisk FactorsNeoplasms, Second PrimaryCarcinoma, Intraductal, NoninfiltratingBreast Self-ExaminationTomography, X-Ray ComputedVinblastineKidney NeoplasmsPositron-Emission TomographyLymph Node ExcisionBiopsy, NeedleMethotrexateSarcomaFluorodeoxyglucose F18Postmenopause